Background: Recent studies have shown that curcumin can reduce the symptoms of hydrocephalus. However, the underlying mechanisms remain unclear. Our previous studies demonstrated that E2F transcription factor 4 (E2F4) protein plays an important role in hydrocephalus; hence, we hypothesized that E2F4 may involve in curcumin mediated anti-hydrocephalus benefits. Methods: E2F4 expression and functions in different human tissues and cell lines were determined and analyzed using the all RNA-seq and ChIP-seq sample and signature search database and ChIP-atlas database. Hydrocephalus mouse model was established through stereotactic injection of shE2F4 into frontal cortex. Mice were treated with curcumin, and then hydrocephalus severity, the expression of E2F4, and downstream targets were analyzed. Results: E2F4 was highly expressed in the nervous system, which was downregulated in the bran of hydrocephalus patients. Knockdown E2F4 in mice could mimic the phenotype of human hydrocephalus. Upon curcumin administration, E2F4 expression level was increased, and the hydrocephalus severity score was significantly decreased in mouse model. Mechanistically, curcumin attenuated hydrocephalus through activating E2F4 signaling pathway. Conclusion: Curcumin suppresses hydrocephalus progression via activation of E2F4, which could be a target for hydrocephalus treatment.

1.
Adzick
NS
,
Thom
EA
,
Spong
CY
,
Brock
JW
 3rd
,
Burrows
PK
,
Johnson
MP
,
A randomized trial of prenatal versus postnatal repair of myelomeningocele
.
N Engl J Med
.
2011
;
364
:
993
1004
.
2.
Rekate
HL
.
A contemporary definition and classification of hydrocephalus
.
Semin Pediatr Neurol
.
2009
;
16
:
9
15
. .
3.
Alperin
N
,
Oliu
CJ
,
Bagci
AM
,
Lee
SH
,
Kovanlikaya
I
,
Adams
D
,
Low-dose acetazolamide reverses periventricular white matter hyperintensities in iNPH
.
Neurology
.
2014
;
82
:
1347
51
.
4.
Yamada
SM
,
Masahira
N
,
Kawanishi
Y
,
Fujimoto
Y
,
Shimizu
K
.
Preoperative acetazolamide SPECT is useful for predicting outcome of shunt operation in idiopathic normal pressure hydrocephalus patients
.
Clin Nucl Med
.
2013
;
38
:
671
6
. .
5.
Adeva-Andany
MM
,
Fernández-Fernández
C
,
Sánchez-Bello
R
,
Donapetry-García
C
,
Martínez-Rodríguez
J
.
The role of carbonic anhydrase in the pathogenesis of vascular calcification in humans
.
Atherosclerosis
.
2015
;
241
:
183
91
. .
6.
Bulli
I
,
Dettori
I
,
Coppi
E
,
Cherchi
F
,
Venturini
M
,
Di Cesare Mannelli
L
,
Role of carbonic anhydrase in cerebral ischemia and carbonic anhydrase inhibitors as putative protective agents
.
Int J Mol Sci
.
2021
;
22
(
9
):
5029
.
7.
Swenson
ER
.
New insights into carbonic anhydrase inhibition, vasodilation, and treatment of hypertensive-related diseases
.
Curr Hypertens Rep
.
2014
;
16
:
467
. .
8.
Zahedi
K
,
Barone
S
,
Xu
J
,
Soleimani
M
.
Potentiation of the effect of thiazide derivatives by carbonic anhydrase inhibitors: molecular mechanisms and potential clinical implications
.
PLoS One
.
2013
;
8
:
e79327
. .
9.
Salameh
TS
,
Shah
GN
,
Price
TO
,
Hayden
MR
,
Banks
WA
.
Blood-brain barrier disruption and neurovascular unit dysfunction in diabetic mice: protection with the mitochondrial carbonic anhydrase inhibitor topiramate
.
J Pharmacol Exp Ther
.
2016
;
359
:
452
9
. .
10.
Supuran
CT
.
Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors
.
Expert Opin Drug Metab Toxicol
.
2016
;
12
:
423
31
. .
11.
Swenson
ER
.
Safety of carbonic anhydrase inhibitors
.
Expert Opin Drug Saf
.
2014
;
13
:
459
72
. .
12.
Adamson
R
,
Swenson
ER
.
Acetazolamide use in severe chronic obstructive pulmonary disease. Pros and Cons
.
Ann Am Thorac Soc
.
2017
;
14
:
1086
93
. .
13.
Kent
LN
,
Leone
G
.
The broken cycle: E2F dysfunction in cancer
.
Nat Rev Cancer
.
2019
;
19
:
326
38
. .
14.
Morgunova
E
,
Yin
Y
,
Jolma
A
,
Dave
K
,
Schmierer
B
,
Popov
A
,
Structural insights into the DNA-binding specificity of E2F family transcription factors
.
Nat Commun
.
2015
;
6
:
10050
.
15.
Zheng
Y
,
Stamminger
T
,
Hearing
P
.
E2F/Rb family proteins mediate interferon induced repression of adenovirus immediate early transcription to promote persistent viral infection
.
PLoS Pathog
.
2016
;
12
:
e1005415
. .
16.
Hsu
J
,
Sage
J
.
Novel functions for the transcription factor E2F4 in development and disease
.
Cell Cycle
.
2016
;
15
:
3183
90
. .
17.
Lestari
ML
,
Indrayanto
G
.
Curcumin
.
Profiles Drug Subst Excip Relat Methodol
.
2014
;
39
:
113
204
. .
18.
Hewlings
SJ
,
Kalman
DS
.
Curcumin: a review of its effects on human health
.
Foods
.
2017
;
6
(
10
):
92
. .
19.
Giordano
A
,
Tommonaro
G
.
Curcumin and cancer
.
Nutrients
.
2019
;
11
. .
20.
Pulido-Moran
M
,
Moreno-Fernandez
J
,
Ramirez-Tortosa
C
,
Ramirez-Tortosa
M
.
Curcumin and health
.
Molecules
.
2016
;
21
(
3
):
264
. .
21.
Qi
Z
,
Zhang
H
,
Fu
C
,
Liu
X
,
Chen
B
,
Dang
Y
,
Prolonged hydrocephalus induced by intraventricular hemorrhage in rats is reduced by curcumin therapy
.
Neurosci Lett
.
2017
;
637
:
120
5
.
22.
Lachmann
A
,
Torre
D
,
Keenan
AB
,
Jagodnik
KM
,
Lee
HJ
,
Wang
L
,
Massive mining of publicly available RNA-seq data from human and mouse
.
Nat Commun
.
2018
;
9
:
1366
.
23.
Conesa
A
,
Götz
S
,
García-Gómez
JM
,
Terol
J
,
Talón
M
,
Robles
M
.
Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research
.
Bioinformatics
.
2005
;
21
:
3674
6
.
24.
Behlke
MA
.
Progress towards in vivo use of siRNAs
.
Mol Ther
.
2006
;
13
:
644
70
. .
25.
Inaba
S
,
Nagahara
S
,
Makita
N
,
Tarumi
Y
,
Ishimoto
T
,
Matsuo
S
,
Atelocollagen-mediated systemic delivery prevents immunostimulatory adverse effects of siRNA in mammals
.
Mol Ther
.
2012
;
20
:
356
66
.
26.
Mammoto
A
,
Connor
KM
,
Mammoto
T
,
Yung
CW
,
Huh
D
,
Aderman
CM
,
A mechanosensitive transcriptional mechanism that controls angiogenesis
.
Nature
.
2009
;
457
:
1103
8
.
27.
Latif-Hernandez
A
,
Shah
D
,
Ahmed
T
,
Lo
AC
,
Callaerts-Vegh
Z
,
Van der Linden
A
,
Quinolinic acid injection in mouse medial prefrontal cortex affects reversal learning abilities, cortical connectivity and hippocampal synaptic plasticity
.
Sci Rep
.
2016
;
6
:
36489
.
28.
Mori
M
,
Hazan
R
,
Danielian
PS
,
Mahoney
JE
,
Li
H
,
Lu
J
,
Cytoplasmic E2f4 forms organizing centres for initiation of centriole amplification during multiciliogenesis
.
Nat Commun
.
2017
;
8
:
15857
.
29.
Park
H
,
Lee
S
,
Shrestha
P
,
Kim
J
,
Park
JA
,
Ko
Y
,
AMIGO2, a novel membrane anchor of PDK1, controls cell survival and angiogenesis via Akt activation
.
J Cell Biol
.
2015
;
211
:
619
37
.
30.
Noorafshan
A
,
Ashkani-Esfahani
S
.
A review of therapeutic effects of curcumin
.
Curr Pharm Des
.
2013
;
19
:
2032
46
. .
31.
Iyirhiaro
GO
,
Zhang
Y
,
Estey
C
,
O’Hare
MJ
,
Safarpour
F
,
Parsanejad
M
,
Regulation of ischemic neuronal death by E2F4-p130 protein complexes
.
J Biol Chem
.
2014
;
289
:
18202
13
.
32.
Gaubatz
S
,
Lees
JA
,
Lindeman
GJ
,
Livingston
DM
.
E2F4 is exported from the nucleus in a CRM1-dependent manner
.
Mol Cell Biol
.
2001
;
21
:
1384
92
. .
33.
Verona
R
,
Moberg
K
,
Estes
S
,
Starz
M
,
Vernon
JP
,
Lees
JA
.
E2F activity is regulated by cell cycle-dependent changes in subcellular localization
.
Mol Cell Biol
.
1997
;
17
:
7268
82
.
34.
Sasagawa
S
,
Nishimura
Y
,
Hayakawa
Y
,
Murakami
S
,
Ashikawa
Y
,
Yuge
M
,
E2F4 promotes neuronal regeneration and functional recovery after spinal cord injury in zebrafish
.
Front Pharmacol
.
2016
;
7
:
119
.
35.
Bala
K
,
Tripathy
BC
,
Sharma
D
.
Neuroprotective and anti-ageing effects of curcumin in aged rat brain regions
.
Biogerontology
.
2006
;
7
:
81
9
. .
36.
Mythri
RB
,
Bharath
MM
.
Curcumin: a potential neuroprotective agent in Parkinson’s disease
.
Curr Pharm Des
.
2012
;
18
:
91
9
. .
37.
Chiu
CF
,
Ghanekar
Y
,
Frost
L
,
Diao
A
,
Morrison
D
,
McKenzie
E
,
Lowe
M
.
ZFPL1, a novel ring finger protein required for cis-Golgi integrity and efficient ER-to-Golgi transport
.
EMBO J
.
2008
;
27
:
934
47
.
38.
Sun
SC
,
Lee
SE
,
Xu
YN
,
Kim
NH
.
Perturbation of Spc25 expression affects meiotic spindle organization, chromosome alignment and spindle assembly checkpoint in mouse oocytes
.
Cell Cycle
.
2010
;
9
:
4552
9
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.